Terms: = Bone cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Clinical Outcome
5 results:
1. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia.
Wu L; Xia M; Sun X; Han X; Zu Y; Jabbour EJ; You MJ; Lin P; Li S; Xu J; Han H; Bueso-Ramos CE; Medeiros LJ; Qiu X; Yin CC
Eur J Haematol; 2020 Oct; 105(4):449-459. PubMed ID: 32535947
[TBL] [Abstract] [Full Text] [Related]
2. Concomitant Waldenstrom macroglobulinemia and iga plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma].
Usnarska-Zubkiewicz L; Mazur G; Wróbel T; Poreba M; Kuliczkowski K
Pol Arch Med Wewn; 2003 Jul; 110(1):719-24. PubMed ID: 14682206
[TBL] [Abstract] [Full Text] [Related]
4. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
Novitzky N; Davison GM; Hale G; Waldmann H
Transplantation; 2002 Dec; 74(11):1551-9. PubMed ID: 12490788
[TBL] [Abstract] [Full Text] [Related]
5. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Sullivan KM; Storek J; Kopecky KJ; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon RP; Anasetti C; Appelbaum FR; Bowden RA; Buckner CD; Crawford SW; Deeg HJ; Hansen JA; McDonald GB; Sanders JE; Storb R
Biol Blood Marrow Transplant; 1996 Feb; 2(1):44-53. PubMed ID: 9078354
[TBL] [Abstract] [Full Text] [Related]
